Invus Public Equities Advisors, LLC, Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 470,792 shares at $12.89 ($6.0M) on 2018-06-08, disclosed to the SEC on 2018-06-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.89 | 29,747 | $383K | 6.4% |
| 2 | $12.89 | 29,747 | $383K | 6.4% |
| 3 | $12.75 | 98,626 | $1.3M | 20.9% |
| 4 | $12.75 | 98,626 | $1.3M | 20.9% |
| 5 | $12.83 | 107,023 | $1.4M | 22.8% |
| 6 | $12.83 | 107,023 |
| $1.4M |
| 22.8% |
| Total | $12.80 avg | 470,792 | $6.0M | 100% |
| Filing → |
| SRRK | BUY | 2022-10-07 | $998K | — | Filing → |